Companies: 10,795·Total market cap: $144.5T
Universal Ibogaine Inc.

Universal Ibogaine Inc.

IBOGFOTCHealthcare● Active
$0.02
$-0.01(-44.90%)
Market Cap$5412452
P/E Ratio—
52W High$0.35
52W Low$0.0023
Overview

Universal Ibogaine Inc. (IBOGF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

IBOGF · cash on hand · updated Jul 31, 2022

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$726,047▲ +410.6% vs prior year
FY · as of Jul 31, 2022 · Reported in CAD
Cash & Cash Equiv. (CCE)
$726,047
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+410.6%
vs prior fiscal year
Latest Quarter
$127,746
Q2 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: July 31, 2022

Net cash vs debt

Cash & ST Investments$726,047Cash on Hand
Total Debt$1.7MTotal Debt
Net Cash / Net Debt−$1.0MNet Debt Position
Cash vs Debt Ratio
Cash 29%Debt 71%

Universal Ibogaine Inc. carries a net debt position of $1.0M. Total debt ($1.7M) exceeds cash on hand ($726,047). Universal Ibogaine Inc. cash vs debt ratio: 29% cash / 71% debt.

Net Cash = Cash & ST Investments − Total Debt$726,047 − $1.7M = −$1.0M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
IBOGF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jul 31, 2022Latest$0.7M+410.6%
Jul 31, 2021$0.1M+96.1%
Mar 31, 2020$0.1M-64.6%
Mar 31, 2019$0.2M+294.7%
Mar 31, 2018$0.1M-86.6%
IBOGF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.5%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Universal Ibogaine Inc.
Universal Ibogaine Inc.YOU
IBOGF
$0.7M13.4%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Universal Ibogaine Inc. (IBOGF) cash on hand as of July 31, 2022 is $726,047, comprising $726,047 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Universal Ibogaine Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Universal Ibogaine Inc. cash reserves or cash position.

Universal Ibogaine Inc. annual cash on hand history shows increased +410.6% in 2022: increased +410.6% in 2022. Universal Ibogaine Inc. cash reserves in 2022 reflect the company's capital allocation strategy.

Universal Ibogaine Inc. carries total debt of $1.7M against cash of $726,047, resulting in a net debt position of -$1.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

IBOGF cash on hand · 5 questions

As of July 31, 2022, Universal Ibogaine Inc. (IBOGF) has $726,047 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $726,047 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (April 30, 2025): $127,746. Data sourced from the annual 10-K filing via FMP.

IBOGF cash on handIBOGF cash reservesIBOGF cash 2022how much cash does IBOGF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Universal Ibogaine Inc. · Universal Ibogaine Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: July 31, 2022